ADAMTS10
protein-codingADAM metallopeptidase with thrombospondin type 1 motif 10, the group of ADAM metallopeptidases with thrombospondin type 1 motif
Gene summary
This gene belongs to the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin type-1 motifs) family of zinc-dependent proteases. ADAMTS proteases are complex secreted enzymes containing a prometalloprotease domain of the reprolysin type attached to an ancillary domain with a highly conserved structure that includes at least one thrombospondin type 1 repeat. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. The product of this gene plays a major role in growth and in skin, lens, and heart development. It is also a candidate gene for autosomal recessive Weill-Marchesani syndrome. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010194
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010194
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018096
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010194
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010194
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Cardiovascular; Ophthalmologic
Rationale: Individuals can have cardiac anomalies, including long QTc, and awareness may allow for preventive/medical management, which may decrease morbidity and mortality; As the condition can include glaucoma, surveillance can allow early interventions that may potentially be beneficial related to preservation of visual status
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADAMTS10 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_030957.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 329 | 3 | 337 | ||
| missense | 2 | 8 | 356 | 20 | 2 | 388 |
| nonsense | 11 | 2 | 2 | 15 | ||
| start loss | 0 | |||||
| frameshift | 8 | 1 | 1 | 10 | ||
| splice donor/acceptor (+/-2bp) | 1 | 7 | 3 | 11 | ||
| Total | 22 | 18 | 367 | 349 | 5 | 761 |
Highest pathogenic variant AF is 0.0000065799863
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_112219.3 | 24 | MANE Select | |
| Ensembl | ENSP00000471851.1 | 24 | MANE Select | |
| RefSeq | NP_001269281.1 | 13 | Standard | |
| Ensembl | ENSP00000270328.4 | 24 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- O-glycosylation of TSR domain-containing proteins
- O-linked glycosylation
Biological Process
- proteolysis
- biological_process
Molecular Function
- molecular_function
- metalloendopeptidase activity
- protein binding
- metal ion binding
Cellular Component
- microfibril
- collagen-containing extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000270328
- Coding exons
- 24
- Length
- 30495
- Individuals with no LoFs
- 125730
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125748
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.63 | 446 | 720 | 0.620 | 0.0000507 | 7077 |
| Missense (PolyPhen) | 109 | 255.08 | 0.42732 | 2605 | ||
| Synonymous | 0.782 | 294 | 312 | 0.944 | 0.0000238 | 2241 |
| Loss of Function | 5.67 | 12 | 59.0 | 0.204 | 0.00000313 | 618 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.000053 | 0.000053 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Metalloprotease that participate in microfibrils assembly. Microfibrils are extracellular matrix components occurring independently or along with elastin in the formation of elastic tissues. {ECO:0000269|PubMed:21402694}.;
- Disease
- DISEASE: Weill-Marchesani syndrome 1 (WMS1) [MIM:277600]: A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma. {ECO:0000269|PubMed:15368195, ECO:0000269|PubMed:18567016}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.476
- RVIS EVS
- -1.32
- RVIS percentile EVS
- 4.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.221
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |